Evolution of pain at 3 months by oral resveratrol in knee osteoarthritis (ARTHROL): protocol for a multicentre randomised double-blind placebo-controlled trial

INTRODUCTION: Osteoarthritis (OA) pathophysiology is driven in part by joint inflammation. Resveratrol has in vitro anti-inflammatory properties. We aim to assess the efficacy of oral resveratrol for knee pain at 3 months in people with knee OA. METHODS AND ANALYSIS: We will conduct a randomised dou...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Christelle, Boutron, Isabelle, Baron, Gabriel, Coudeyre, Emmanuel, Berenbaum, Francis, Poiraudeau, Serge, Rannou, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Rehabilitation Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640106/
https://www.ncbi.nlm.nih.gov/pubmed/28965100
http://dx.doi.org/10.1136/bmjopen-2017-017652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640106/
https://www.ncbi.nlm.nih.gov/pubmed/28965100
http://dx.doi.org/10.1136/bmjopen-2017-017652

Ejemplares similares